Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3,4-dihydropyran
1. 110-87-2
2. Dihydropyran
3. 3,4-dihydropyran
4. 2h-3,4-dihydropyran
5. 2,3-dihydro-4h-pyran
6. Dihydro-2h-pyran
7. 2,3-dihydropyran
8. 2h-pyran, 3,4-dihydro-
9. 5,6-dihydro-4h-pyran
10. 2h-pyran, Dihydro-
11. Dihydropyrane
12. .delta.2-dihydropyran
13. Pyran, Dihydro-
14. 3,4-dihydro-2-pyran
15. Nsc 57860
16. T6v9n71ihx
17. 1,2-pyran, 3,4-dihydro-
18. Nsc-57860
19. Nsc-73472
20. Wln: T6o Butj
21. 2,3-dihydropyrane
22. Delta2-dihydropyran
23. Dihydropyran (van)
24. 3,4-dihydro-2h-pyrane
25. Mfcd00006558
26. Unii-t6v9n71ihx
27. Dihyrdopyran
28. Dihyropyran
29. Dihydro-2h-pyran, 3,4-
30. 2,3dihydropyran
31. 2,3-dihyropyran
32. 2,4-dihydropyran
33. 4,5-dihydropyran
34. 3,4-dihydropyrane
35. Einecs 203-810-4
36. 2,3-dihydro-pyran
37. 3,4-dihydro-pyran
38. Un2376
39. 3,4dihydro-2h-pyran
40. 3,4-dihyro-2h-pyran
41. Pyran, 2,3-dihydro-
42. 3,4-dihydro-2h Pyran
43. Ai3-16497
44. 3, 4dihydro-2h-pyran
45. 3,4 Dihydro-2h-pyran
46. 3,4-dihydro 2h-pyran
47. 3,4-dihydro-1h-pyran
48. 3.4-dihydro-2h-pyran
49. 2,3-dihydro-4h-pyrane
50. 3,4-dihdro-2h-pyrane
51. 3,4-dihydro(2h)pyran
52. Dihydropyran [mi]
53. 2,3-dihydro-4-h-pyran
54. 3,4- Dihydro-2h-pyran
55. 3,4-dihydro-2 H-pyran
56. 3,4-dihydro-2-h-pyran
57. 3,4-dihydro-2h -pyran
58. 3,4-dihydro-2-h-pyrane
59. Ec 203-810-4
60. 3,4-dihydro-[2h]-pyran
61. Dsstox_cid_21426
62. Dsstox_rid_79730
63. .delta.(sup2)-dihydropyran
64. 3,4 - Dihydro-2h-pyran
65. Dsstox_gsid_41426
66. Chembl3184439
67. Dtxsid6041426
68. 3,4-dihydro-2h-pyran, 97%
69. 2-pyran, 3,4-dihydro-
70. Act05913
71. Amy39440
72. Nsc57860
73. Nsc73472
74. Str01188
75. Zinc4726938
76. 2,3-dihydro-.gamma.-pyran
77. Tox21_301188
78. Stl146593
79. Akos000121126
80. Cs-w013755
81. Ncgc00248323-01
82. Ncgc00255086-01
83. Bp-21473
84. Cas-110-87-2
85. Db-002492
86. D0555
87. D78128
88. 2,3-dihydropyran [un2376] [flammable Liquid]
89. 3,4-dihydro-2h-pyran, Purum, >=95.0% (gc)
90. Q419349
91. J-511179
92. F0001-0228
| Molecular Weight | 84.12 g/mol |
|---|---|
| Molecular Formula | C5H8O |
| XLogP3 | 0.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 84.057514874 g/mol |
| Monoisotopic Mass | 84.057514874 g/mol |
| Topological Polar Surface Area | 9.2 Ų |
| Heavy Atom Count | 6 |
| Formal Charge | 0 |
| Complexity | 57 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
21
PharmaCompass offers a list of 3,4-Dihydro-2H-Pyran API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 3,4-Dihydro-2H-Pyran manufacturer or 3,4-Dihydro-2H-Pyran supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 3,4-Dihydro-2H-Pyran manufacturer or 3,4-Dihydro-2H-Pyran supplier.
PharmaCompass also assists you with knowing the 3,4-Dihydro-2H-Pyran API Price utilized in the formulation of products. 3,4-Dihydro-2H-Pyran API Price is not always fixed or binding as the 3,4-Dihydro-2H-Pyran Price is obtained through a variety of data sources. The 3,4-Dihydro-2H-Pyran Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 3,4-Dihydro-2H-Pyran manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3,4-Dihydro-2H-Pyran, including repackagers and relabelers. The FDA regulates 3,4-Dihydro-2H-Pyran manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3,4-Dihydro-2H-Pyran API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 3,4-Dihydro-2H-Pyran supplier is an individual or a company that provides 3,4-Dihydro-2H-Pyran active pharmaceutical ingredient (API) or 3,4-Dihydro-2H-Pyran finished formulations upon request. The 3,4-Dihydro-2H-Pyran suppliers may include 3,4-Dihydro-2H-Pyran API manufacturers, exporters, distributors and traders.
3,4-Dihydro-2H-Pyran Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 3,4-Dihydro-2H-Pyran GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 3,4-Dihydro-2H-Pyran GMP manufacturer or 3,4-Dihydro-2H-Pyran GMP API supplier for your needs.
A 3,4-Dihydro-2H-Pyran CoA (Certificate of Analysis) is a formal document that attests to 3,4-Dihydro-2H-Pyran's compliance with 3,4-Dihydro-2H-Pyran specifications and serves as a tool for batch-level quality control.
3,4-Dihydro-2H-Pyran CoA mostly includes findings from lab analyses of a specific batch. For each 3,4-Dihydro-2H-Pyran CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
3,4-Dihydro-2H-Pyran may be tested according to a variety of international standards, such as European Pharmacopoeia (3,4-Dihydro-2H-Pyran EP), 3,4-Dihydro-2H-Pyran JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3,4-Dihydro-2H-Pyran USP).
